490 BioTech welcomes EDITHGEN as our new distributor in South Korea
To better serve our customers in South Korea, 490 BioTech is pleased to welcome EDITHGEN as our new product distributor.
490 BioTech prepares for International Space Station launch
490 BioTech heads to space on-board the SpaceX Falcon 9 rocket for the 14th resupply mission to the International Space Station scheduled for liftoff at 4:30 p.m. EDT, Monday, April 2nd. Read all about our autobioluminescent cell lines in space and how they will be used to test the metabolic impact of drug compounds in microgravity.
490 BioTech receives NIH Phase II SBIR award for improving drug discovery screens and 3D microphysiological assays
490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens that are more predictive of pharmacological safety and toxicity. Using our autobioluminescent expression system, we will create novel data-intensive, autonomous,…
490 BioTech partners with Applied StemCell for new regenerative medicine in vivo models
490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in vivo rodent models endowed with our patented autobioluminescent expression technology for the continuous and non-invasive surveillance of stem cell…
Funakoshi Co., Ltd. joins our distributor network
490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.
SouthFound Media interviews our Chief Science Officer, Dan Close
SouthFound Media recently interviewed Dan Close, 490 BioTech’s Chief Science Officer, to discuss our autobioluminescent technology and the newest research we are pursuing. Watch it here.